TRANSCEND Transcending limitations of translational research on Multiple Sclerosis and Autism Spectrum Disorder - Spectral, brain-related disorder, patient outcomes, cognition, effect, symptoms
- Coordinator
- Aarhus Universitet, Denmark
- Runs
- 1 September 2025 to 31 August 2029
- Status
- Running
- EU funding
- €4.0m
- Total cost
- —
- Partners
- 22 organisations in 9 countries
- Type
- Marie Skłodowska-Curie Action
- Grant agreement
- 101226660
What the project is doing
In the project's own words, from its summary on CORDIS.
TRANSCEND brings together expertise in biomedical, computational, behavioural, clinical, epidemiological and philosophicalresearch to advance translational research in medicine. TRANSCEND aims to add to the chronological and epistemic order of research from bench to bedside to practice with a more networked-based understanding of translation. This is particularly important in translational research on complex and chronic neurological conditions where the few low-hanging fruits of reductionist approaches seem to have been picked.
TRANSCEND involves nine interlinked laboratories from clinical, biomedical, metamethodological, and philosophical sub-projects, which focus on autism spectrum disorder and multiple sclerosis. These conditions are characterised by an interconnected set of physical, cognitive and psychological symptoms, and unknown underlying disease mechanisms. While healthcare has been moving away from a purely single-cause view of medicine towards interconnected concepts of positive health, such a more complicated and nuanced notion of health and dis/ability is unintegrated within biomedical research.
Most research designs are not well-suited to consider patient-relevant outcomes, the biological and social complexity of these conditions, and their implications in real-world healthcare settings, because their epistemology is oriented towards purification and reduction concerning research questions, disease models, and experiments. TRANSCEND proposes an integrative approach to translational research that embraces instead of reduces the complexity and diversity of the biological, clinical and social manifestations of the diagnoses.
It will provide an innovative, interdisciplinary training along four research objectives to overcome key limitations of translational research on complex, chronic conditions: (1) making animal models more translational; (2) focusing on patient outcomes and scoping “disease” categories; (3) rethinking theragnostic strategies.
Topics
Who is involved
| Organisation | City | Country | Role |
|---|---|---|---|
| Aarhus Universitet | Aarhus C | Denmark | Coordinator |
| European Animal Research Association | Bruxelles / Brussel | Belgium | Associatedpartner |
| Katholieke Universiteit Leuven | Leuven | Belgium | Participant |
| Eidgenoessische Technische Hochschule Zuerich | Zuerich | Switzerland | Associatedpartner |
| Idorsia Pharmaceuticals Ltd | Allschwil | Switzerland | Associatedpartner |
| Bundesministerium Fuer Gesundheit | Bonn | Germany | Associatedpartner |
| Universitaet Bielefeld | Bielefeld | Germany | Participant |
| Kobenhavns Universitet | Kobenhavn | Denmark | Participant |
| Saber Bio | Paris | France | Associatedpartner |
| Universite Bordeaux Montaigne | Pessac Cedex | France | Participant |
| Ospedale San Raffaele SRL | Milano | Italy | Associatedpartner |
| Universita Vita-Salute San Raffaele | Milano | Italy | Participant |
| Ink BV | Amsterdam | Netherlands | Associatedpartner |
| Orikami B.V. | Nijmegen | Netherlands | Associatedpartner |
| Stichting Amsterdam Umc | Amsterdam | Netherlands | Participant |
| Stichting Radboud Universiteit | Nijmegen | Netherlands | Participant |
| Stichting MS Research | Voorschoten | Netherlands | Associatedpartner |
| Universitair Medisch Centrum Utrecht | Utrecht | Netherlands | Participant |
| Universiteit Utrecht | Utrecht | Netherlands | Associatedpartner |
| Vereniging Voor Christelijk Hoger Onderwijs Wetenschappelijk Onderzoek En Patientenzorg | Amsterdam | Netherlands | Associatedpartner |
| Universitetet I Oslo | Oslo | Norway | Participant |
| Universidade Do Porto | Porto | Portugal | Participant |
Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS